Chronic spontaneous urticaria management by Italian general practitioners before and after implementation of an urticaria care package: Survey results from the BRIDGE study
Introduction General practitioners (GPs) often lack knowledge of chronic spontaneous urticaria (CSU) and its management guidelines. An educational urticaria care package (UCP) was developed to improve CSU management and use of patient-reported outcome measures (PROMs) in CSU. The impact, feasibility, and utility of the UCP were evaluated in the effectiveness-implementation BRIDGE study among GPs in Lombardy, Italy, the pilot region. Methods GPs completed self-administered surveys before (May–July 2024) and after (April–June 2025) UCP implementation. Survey topics included CSU awareness and knowledge, CSU-specific or other PROM use, attitudes toward UCP implementation, implementation climate, and factors influencing UCP implementation. Pre- and post-implementation survey results were compared to assess the effectiveness of the UCP. Results Of 95 GPs who completed the pre-implementation survey, 92 also completed the post-implementation survey. After UCP implementation, GPs reported on average 4 patients with suspected CSU, 3 patients diagnosed with CSU, 2 patients treated for CSU, and 3 patients with suspected CSU referred to a specialist over the previous 6 months. The most common reasons for referral were to confirm CSU diagnosis and seek a specialist's opinion, both before and after implementation. The proportion of GPs referring patients because they felt unconfident in diagnosing or treating CSU decreased from 42.7% (35/82) before implementation to 16.0% (13/81) after implementation. Before implementation, 40.0% (38/95) of GPs reported having knowledge of CSU and 38.9% (37/95) were aware of CSU guidelines. After implementation, the corresponding proportions increased to 78.3% (72/92) and 96.7% (89/92), respectively. The proportion of GPs who ever used a PROM increased by 41.4% (95% CI 31.0%–51.7%) post-implementation, corresponding to a relative increase of 400.0% (95% CI 244.4%–833.3%). Among GPs with PROM experience, none used PROMs with patients with CSU before implementation, while 88.9% (40/45) did so after implementation. The absolute increase from pre-to post-implementation in the proportion of GPs having used a CSU-specific PROM in the previous 6 months was 46.0% (95% CI 35.5%–56.4%). Compared with pre-implementation, after implementation more GPs agreed or strongly agreed that using PROMs for CSU would be beneficial. Most GPs perceived positive changes in their management of patients with CSU since using the UCP and considered the UCP useful. Conclusions The results suggest the UCP's effectiveness in enhancing awareness of CSU management guidelines and increasing PROM use among GPs in the Lombardy region of Italy and support its wider implementation, both within Italy and in other countries.
Authors
- Riccardo Asero (ORCID: https://orcid.org/0000-0002-8277-1700)
- Mahrukh Zahid
- Pallavi Prakash Saraswat (ORCID: https://orcid.org/0000-0002-4374-9543)
- Patrick Daniele (ORCID: https://orcid.org/0000-0002-7996-4472)
- Nadine Chapman‐Rothe
- Ornella Bonavita
- Piergiacomo Calzavara‐Pinton (ORCID: https://orcid.org/0000-0002-0935-7204)
- Enrico Iemoli (ORCID: https://orcid.org/0000-0003-1510-9677)
- Abigail N. Herbst
- Bridget Gaglio (ORCID: https://orcid.org/0000-0003-1020-3066)
- Tara C. Raftery
- Viviane Sprecher
- Fabio Speranza (ORCID: https://orcid.org/0009-0000-2080-3423)
Institutions
- Novartis (Switzerland) (CH)
- Novartis (India) (IN)
- Thermo Fisher Scientific (Canada) (CA)
- Thermo Fisher Scientific (United Kingdom) (GB)
- Novartis (Italy) (IT)
- Thermo Fisher Scientific (United States) (US)
- Novartis (Ireland) (IE)
- University of Brescia (IT)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1016/j.waojou.2026.101491
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00